Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Withdrawn 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 19Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma 13Myelodysplastic Syndromes 12Lymphoma, Mantle-Cell 12Primary Myelofibrosis 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Accelerated Phase 9Congenital Abnormalities 9Neoplasms, Plasma Cell 8Leukemia, Myeloid, Chronic-Phase 8Graft vs Host Disease 8Anemia, Refractory, with Excess of Blasts 8Recurrence 7Myeloproliferative Disorders 7Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7Dendritic Cell Sarcoma, Interdigitating 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Cyclosporine × Clear all
NCT00001880 2021-11-10

Stem Cell Transplantation for Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
42 enrolled 11 charts

Graft vs Host Disease, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡